Tutorials › VEE Accounting and Finance › Comparing Warrants And Convertibles For Financing

VEE Accounting and Finance · Options in Corporate Finance · Tutorial 970 of 996

Comparing Warrants And Convertibles For Financing

Learn how warrants and convertible bonds create different cash flows, repayment obligations, dilution, and distributions of value.

Advanced 12 min read

What You'll Learn

  • Distinguish cash received at issuance from cash received later when warrants are exercised.
  • Calculate diluted share value and warrant-holder value after exercise.
  • Determine when a convertible bond is converted rather than repaid.
  • Compare debt repayment, dilution, and investor value across financing structures.
  • Identify why terminal payouts alone do not establish which financing is cheaper.

Why the Financing Claim Matters

A company can raise capital with debt that includes warrants or by issuing a convertible bond. Both arrangements can give investors access to equity value, but they do not create the same claims. A warrant holder typically pays an exercise price later to receive shares, while a convertible bondholder exchanges a debt claim for shares and thereby gives up repayment of the bond. Those differences affect how much cash reaches the company, whether principal must be repaid, and how value is divided among investors.

The comparison below focuses on the claims and cash flows at maturity. It uses simplified hypothetical firms with no taxes, transaction costs, dividends, or other securities unless stated. Dollar amounts and share counts are often expressed in millions; dividing millions of dollars by millions of shares gives dollars per share. A terminal value calculation is not, by itself, a valuation of the financing at issuance: that also depends on issue prices, timing, and risk.

Definition: A warrant gives its holder the right, but not the obligation, to buy a specified number of newly issued shares at a stated exercise price. A convertible bond is debt that gives its holder the right, under the contract terms, to exchange the bond for a specified number of shares. If conversion occurs, the bondholder generally surrenders the bond’s principal claim; conversion is not normally a separate cash exercise payment to the issuer.

Two Different Paths From Financing to Shares

Suppose the company has \(N\) existing shares. With warrants, the company may issue debt and warrants together, or sell warrants separately. Any cash paid for the warrants at issuance is an initial financing receipt. If holders later exercise \(W\) warrants at price \(K\) per share, the company receives an additional \(WK\) in cash and issues \(W\) shares. The debt remains outstanding unless it is separately repaid, refinanced, or otherwise changed.

With a convertible bond, the company receives the bond’s issue proceeds at issuance. At maturity, a holder who converts receives shares according to the conversion ratio, usually in place of principal repayment. A holder who does not convert retains the debt claim, subject to the issuer’s ability to pay. Thus, conversion can avoid a cash repayment, but it increases the number of shares and dilutes existing ownership.

Model assumptions for the following maturity calculations: Let \(V\) be the company’s value available to equity and debt claims immediately before any warrant exercise. There are no other senior claims. Debt with face amount \(D\) is paid before equity if the company has sufficient value. For warrants, \(W\) newly issued shares have exercise price \(K\). For a convertible bond, conversion gives the bondholder \(m\) shares, and the bond has face amount \(D\). These simplified formulas do not include default costs, taxes, or contractual features such as call provisions.

After debt is paid, the value available to existing shareholders and warrants is \(E=V-D\), when \(V\geq D\). If the warrants are exercised, the company receives \(WK\), and there are \(N+W\) shares. The post-exercise share price is therefore \((E+WK)/(N+W)\). Exercise is worthwhile when that price exceeds \(K\); equivalently, when \(E>NK\). If the company’s equity value is below the debt due, this simple solvent-company calculation must be replaced with a default recovery analysis.

Why the Warrant Dilution Formula Holds

The diluted share price is found by combining the value already available to equity with the cash paid upon exercise, then dividing by all shares outstanding after exercise. This is not the same as dividing the pre-exercise equity value by the new share count: the latter would incorrectly omit the cash the company receives.

$$ P_{\text{after}}=\frac{E+WK}{N+W} $$

The warrant holders receive \(W\) shares worth \(W P_{\text{after}}\), but they pay \(WK\) to obtain them. Their net value at exercise is therefore \(W(P_{\text{after}}-K)\). To find the exercise condition, require \(P_{\text{after}}>K\), substitute the diluted price, and multiply by the positive quantity \(N+W\):

$$ \frac{E+WK}{N+W}>K \quad\Longleftrightarrow\quad E+WK>NK+WK \quad\Longleftrightarrow\quad E>NK. $$

The corresponding conversion comparison is different. If conversion gives \(m\) shares and no debt remains after conversion, the conversion shares are worth \(mV/(N+m)\). The bondholder compares that amount with the debt payment available under the contract. In the simplified solvent case, conversion is preferable to receiving \(D\) when:

$$ \frac{mV}{N+m}>D \quad\Longleftrightarrow\quad V>\frac{D(N+m)}{m}. $$

This threshold assumes the bondholder can receive the full \(D\) if not converting. If the company cannot pay in full, default recovery and any bond priority must be considered instead.

Worked Example: Calculating Warrant Dilution and Holder Value

A hypothetical company has equity value of \(54\) million dollars after paying all debt, \(3\) million existing shares, and \(1\) million warrants with an exercise price of \(15\) dollars. Assume all warrants are exercised if rational. Find the post-exercise share price, the warrant holders’ net value, and the existing shareholders’ total share value.

Method. Include exercise proceeds in the post-exercise equity value, then divide by the total shares. The exercise proceeds are \(1\times15=15\) million dollars. The total number of shares after exercise is \(3+1=4\) million.

$$ P_{\text{after}}=\frac{54+15}{3+1} =\frac{69}{4} =17.25\text{ dollars per share}. $$

The post-exercise price, \(17.25\), exceeds the \(15\)-dollar exercise price, so exercise is rational. The warrant holders receive shares worth \(1\times17.25=17.25\) million dollars and pay \(15\) million dollars. Their net value is \(17.25-15=2.25\) million dollars. Existing shareholders hold \(3\) million shares worth \(3\times17.25=51.75\) million dollars.

Check. The company’s post-exercise equity value is \(69\) million dollars. The four million shares are worth \(4\times17.25=69\) million dollars. The warrant holders’ net value plus existing shareholders’ value is \(2.25+51.75=54\) million dollars, the original equity value; the holders’ \(15\) million dollar exercise payment is the additional cash in the company.

Comparing Debt With Warrants and a Convertible Bond

A useful comparison keeps the number of existing shares and the company’s pre-exercise terminal value fixed. The following hypothetical example assumes both financing arrangements raise \(10\) million dollars at issuance. One arrangement is a \(10\)-million-dollar bond with \(1\) million warrants at a \(12\)-dollar exercise price. The other is a \(10\)-million-dollar convertible bond that converts into \(1\) million shares. The company has \(4\) million existing shares. At maturity, examine values of \(40\) million and \(80\) million dollars. Ignore interest and treat the \(10\)-million-dollar face amount as the full debt payment due at maturity.

Worked Example: Tracing Claims in Low- and High-Value Outcomes

Low-value outcome: \(V=40\) million dollars. Under debt with warrants, the bond is paid \(10\) million dollars, leaving \(E=40-10=30\) million dollars for equity. The pre-exercise share value is \(30/4=7.50\) dollars, below the \(12\)-dollar exercise price. The warrants are not exercised; the company receives no exercise cash, and existing shareholders retain \(30\) million dollars of value.

For the convertible bond, conversion would give the bondholder \(1\) million shares worth \(40/(4+1)=8\) million dollars. Because \(8\) million is less than the \(10\)-million-dollar repayment available, the holder does not convert. The bond is repaid \(10\) million dollars and existing shareholders retain \(40-10=30\) million dollars.

High-value outcome: \(V=80\) million dollars. With debt and warrants, the bond is paid \(10\) million dollars, leaving \(E=70\) million dollars for equity. If warrants are exercised, the company receives \(1\times12=12\) million dollars. There are then \(5\) million shares, and the post-exercise price is \((70+12)/5=16.40\) dollars. Since \(16.40>12\), exercise is rational. Warrant holders’ net value is \(1\times(16.40-12)=4.40\) million dollars. Existing shareholders’ shares are worth \(4\times16.40=65.60\) million dollars; the bondholders receive \(10\) million dollars.

For the convertible bond, conversion gives the bondholder shares worth \(1\times80/(4+1)=16\) million dollars, more than the \(10\)-million-dollar repayment. The holder converts, receives shares worth \(16\) million dollars, and receives no separate principal payment. Existing shareholders’ shares are worth \(4\times16=64\) million dollars.

Check. In the high-value warrant case, the company has \(80+12=92\) million dollars after exercise cash arrives. Its debt claim is \(10\) million dollars and its shares are worth \(5\times16.40=82\) million dollars, for \(92\) million dollars total. In the convertible case, the five million shares divide \(80\) million dollars: \(64+16=80\). The exercise payment and the surrendered debt claim are treated differently in each financing structure.

Comparing Value Across Several Outcomes

A single outcome can obscure how claims behave in different states. Consider another hypothetical firm with \(3\) million existing shares and terminal values of \(45\) million dollars with probability \(0.25\), and \(75\) million dollars with probability \(0.75\). Compare a \(9\)-million-dollar debt claim plus \(1\) million warrants exercisable at \(10\) dollars with a \(9\)-million-dollar convertible bond that converts into \(1\) million shares. These probabilities describe the hypothetical scenario; they are not market estimates.

Worked Example: Expected Terminal Value by Financing Claim

Debt with warrants at \(V=45\). Debt repayment leaves \(45-9=36\) million dollars. Exercise would produce a post-exercise price of \((36+10)/(3+1)=11.50\) dollars, above the strike. The warrants are exercised, the holder’s net value is \(1\times(11.50-10)=1.50\) million dollars, and existing shares are worth \(3\times11.50=34.50\) million dollars.

Debt with warrants at \(V=75\). Debt repayment leaves \(66\) million dollars. The post-exercise price is \((66+10)/4=19\) dollars. Warrant-holder net value is \(1\times(19-10)=9\) million dollars, and existing shares are worth \(3\times19=57\) million dollars. Debt holders receive \(9\) million dollars in either outcome.

The expected terminal value of the warrants’ net claim is \(0.25(1.50)+0.75(9)=7.125\) million dollars. Existing shareholders’ expected value is \(0.25(34.50)+0.75(57)=51.375\) million dollars. Adding the \(9\)-million-dollar debt payment gives \(7.125+51.375+9=67.5\) million dollars, equal to expected terminal value \(0.25(45)+0.75(75)=67.5\) million dollars.

Convertible bond at \(V=45\). Conversion value is \(1\times45/4=11.25\) million dollars, exceeding the \(9\)-million-dollar repayment. The holder converts; existing shares are worth \(3\times11.25=33.75\) million dollars, and the bondholder’s shares are worth \(11.25\) million dollars.

Convertible bond at \(V=75\). Conversion value is \(75/4=18.75\) million dollars, again exceeding repayment. Existing shares are worth \(3\times18.75=56.25\) million dollars, while the bondholder receives shares worth \(18.75\) million dollars. The convertible holder’s expected value is \(0.25(11.25)+0.75(18.75)=16.875\) million dollars. Existing shareholders’ expected value is \(0.25(33.75)+0.75(56.25)=50.625\) million dollars. Their sum is \(67.5\) million dollars.

Check. In the low-value convertible outcome, \(11.25+33.75=45\); in the high-value outcome, \(18.75+56.25=75\). These are terminal allocations, not proof that one security was more expensive to issue. A fair financing comparison also requires the amounts investors paid and the value and risk of the claims at issuance.

What the Comparison Reveals

FeatureDebt with warrantsConvertible bond
Cash at issuanceBond proceeds and, if separately priced, any warrant sale proceedsBond proceeds
Cash at exercise or conversionExercise brings \(WK\) cash to the company if warrants are exercisedConversion generally brings no new exercise cash
Debt after equity participationDebt remains payable unless separately dischargedConverted bond is surrendered; principal is not also repaid
New shares\(W\) shares if warrants are exercised\(m\) shares if the bond converts
Claim when equity value is lowWarrants can expire unexercised; debt still has its repayment claimBondholder can retain the debt claim, subject to default recovery

The distinction matters to the issuer’s cash planning. A warrant exercise can deliver additional cash precisely when the equity value makes exercise attractive, but the company still faces its debt obligation. A convertible can reduce or eliminate a principal cash payment when conversion is worthwhile, but it does not provide a second exercise-price payment at conversion. The investor’s payoff also differs: warrant holders pay for shares when they exercise, while converting bondholders exchange a debt claim for shares.

Common Mistakes and Exam Traps

  • Omitting exercise proceeds. A mistaken diluted-price calculation in the high-value example is \(70/5=14\) dollars. It incorrectly excludes the \(12\) million dollars paid upon exercise. The correct calculation is \((70+12)/5=16.40\) dollars.
  • Counting both conversion and repayment. If a convertible bond converts, do not add its principal repayment to the value of the conversion shares. The bondholder has surrendered the debt claim.
  • Treating warrants like conversion rights. Exercising warrants brings cash to the issuer; converting a bond normally exchanges a claim rather than bringing a strike payment. These are different cash flows.
  • Ignoring dilution when comparing per-share values. Use \(N+W\) shares after warrant exercise or \(N+m\) shares after conversion. Using only \(N\) overstates the value per share.
  • Comparing terminal values as if they were issuance costs. Different claims can distribute the same firm value differently. To decide which financing is cheaper, compare issue proceeds and appropriately valued future claims, accounting for timing and risk.
Key takeaway: Warrants add shares only upon exercise and bring exercise cash, while convertible bonds replace a debt claim with shares and generally avoid principal repayment if converted. Compare both the cash flows and the diluted ownership; neither structure is inherently cheaper without considering the terms and value at issuance.

Check Your Understanding

For each hypothetical case, state the relevant maturity cash flow or value. Amounts and shares are in millions unless specified.

  1. A firm has \(18\) million dollars of equity value after debt, \(2\) million existing shares, and \(0.5\) million warrants with an \(8\)-dollar exercise price. If all warrants are exercised, calculate the diluted share price and the warrant holders’ aggregate net value. (Answer: \(8.80\) dollars per share; \(0.40\) million dollars.)
  2. A convertible bond has face amount \(6\) million dollars and converts into \(0.5\) million shares. There are \(3\) million existing shares and terminal company value is \(42\) million dollars. Calculate conversion value and state whether the holder prefers conversion or full repayment, assuming the full face amount is payable. (Answer: conversion value \(6\) million dollars; the holder is indifferent.)
  3. A firm has \(2\) million existing shares, \(8\) million dollars of debt due, and \(1\) million warrants at a \(5\)-dollar strike. Terminal value is \(25\) million dollars before exercise. Find the warrant exercise decision, post-exercise share price, and warrant holders’ net value. (Answer: exercise; \(7.33\) dollars per share; \(2.33\) million dollars.)
  4. A convertible bond with \(12\) million dollars face value converts into \(1\) million shares. The firm has \(4\) million existing shares and terminal value of \(72\) million dollars. Calculate the conversion value and the value left for existing shareholders if conversion occurs. (Answer: conversion; bondholder shares worth \(14.40\) million dollars; existing shares worth \(57.60\) million dollars.)
  5. A firm has \(3\) million existing shares. Terminal value is \(30\) million dollars with probability \(0.40\) and \(70\) million dollars with probability \(0.60\). Compare (a) \(8\) million dollars of debt plus \(1\) million warrants at a \(10\)-dollar strike and (b) an \(8\)-million-dollar convertible bond exchangeable for \(1\) million shares. Find expected warrant-holder net value and expected convertible-holder value. Assume full debt repayment is possible in the low state. (Answer: expected warrant-holder net value \(4.80\) million dollars; expected convertible-holder value \(13.70\) million dollars.)
Clinical Biostats